BN revenueFY2025$75.10B
- FY YoY
- -12.7%
- 5Y CAGR
- +3.7%
BN revenue was $75.10B for fiscal 2025 (ended Dec 31, 2025), down 12.7% from fiscal 2024. Compound annual growth was +3.7% over 5 years. It rose in 6 of the last 9 fiscal years.
Financials · BN
For fiscal 2025 (ended Dec 31, 2025), Brookfield Corporation reported $75.10B of revenue and $1.31B of net income.
BN revenue was $75.10B for fiscal 2025 (ended Dec 31, 2025), down 12.7% from fiscal 2024. Compound annual growth was +3.7% over 5 years. It rose in 6 of the last 9 fiscal years.
BN net income was $1.31B for fiscal 2025 (ended Dec 31, 2025), up 103.9% from fiscal 2024. It rose in 1 of the last 4 fiscal years.
BN diluted EPS was $0.49 for fiscal 2025 (ended Dec 31, 2025), up 145.0% from fiscal 2024.
BN free cash flow was -$3.79B for fiscal 2025 (ended Dec 31, 2025), compared with -$3.60B in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.10B | $86.01B | $95.92B | $92.77B | $75.73B | $62.75B | $67.83B | $56.77B | $40.79B | $24.41B |
| Cost of revenue | $28.35B | $40.12B | $52.22B | $54.04B | $44.15B | $35.15B | $41.46B | $37.51B | $26.46B | $12.49B |
| Gross profit | $46.75B | $45.88B | $43.70B | $38.73B | $31.58B | $27.60B | $26.36B | $19.27B | $14.32B | $11.92B |
| Selling, general and admin | $5.13B | $4.93B | $5.35B | $3.93B | $3.20B | $2.86B | $2.61B | $1.76B | $1.34B | $1.54B |
| Interest expense | - | - | - | $10.70B | $7.60B | $7.21B | $7.23B | $4.85B | $3.61B | $3.23B |
| Income tax | $1.14B | $982.00M | $1.01B | $1.47B | $2.32B | $837.00M | $495.00M | -$248.00M | $613.00M | -$345.00M |
| Net income | $1.31B | $641.00M | $1.13B | $2.06B | $3.97B | -$134.00M | $2.81B | $3.58B | $1.46B | $1.65B |
| EPS, basic | $0.51 | $0.21 | $0.41 | $0.81 | $1.65 | -$0.08 | $1.19 | $1.54 | $0.61 | $0.70 |
| EPS, diluted | $0.49 | $0.20 | $0.41 | $0.79 | $1.59 | -$0.08 | $1.15 | $1.51 | $0.60 | $0.69 |
| Diluted shares | 2.37B | 2.38B | 2.38B | 2.41B | 2.38B | 2.27B | 2.23B | 2.20B | 2.20B | - |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $16.24B | $15.05B | $11.22B | $14.40B | $12.69B | $9.93B | $6.78B | $8.39B | $5.14B | $4.30B |
| Receivables | $22.77B | $20.28B | $20.26B | $19.49B | $16.10B | $14.19B | $13.86B | $11.91B | $8.49B | $6.49B |
| Inventory | $5.92B | $5.42B | $7.06B | $9.11B | $8.56B | $6.34B | $7.05B | $4.58B | $3.58B | $2.99B |
| Current assets | - | - | - | - | - | - | - | - | $9.64B | $6.83B |
| Goodwill | $43.35B | $35.73B | $34.91B | $28.66B | $20.23B | $14.71B | $14.55B | $8.81B | $5.32B | $3.78B |
| Total assets | $518.97B | $490.42B | $490.10B | $441.28B | $391.00B | $343.70B | $323.97B | $256.28B | $192.72B | $159.83B |
| Current liabilities | - | - | - | - | - | - | - | - | $10.31B | $10.69B |
| Long-term debt | $13.80B | - | - | - | - | - | - | - | - | - |
| Total debt | $13.80B | $14.23B | $12.16B | $11.39B | $10.88B | $9.08B | $7.08B | $6.41B | $5.66B | $52.44B |
| Total liabilities | $352.78B | $325.04B | $321.85B | $299.39B | $256.26B | $221.05B | $207.12B | $159.13B | $112.85B | $90.14B |
| Shareholders' equity | $166.19B | $165.38B | $168.24B | $141.89B | $134.74B | $122.64B | $116.85B | $97.15B | $79.87B | $69.69B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.96B | $7.57B | $6.47B | $8.75B | $7.87B | $8.34B | $6.33B | $5.16B | $4.00B | $3.08B |
| Capital expenditures | $14.75B | $11.17B | $8.07B | $7.24B | $6.88B | $4.01B | $3.05B | $1.96B | $1.69B | $1.47B |
| Free cash flow | -$3.79B | -$3.60B | -$1.60B | $1.51B | $993.00M | $4.33B | $3.27B | $3.20B | $2.31B | $1.61B |
| Investing cash flow | -$31.78B | -$29.96B | -$29.76B | -$39.65B | -$21.05B | -$13.87B | -$36.67B | -$19.83B | -$11.39B | -$8.56B |
| Financing cash flow | $21.69B | $26.90B | $19.93B | $32.46B | $16.26B | $8.70B | $28.75B | $18.14B | $8.19B | $6.99B |
| Depreciation and amortization | $10.38B | $9.74B | $9.07B | $7.68B | $6.44B | $5.79B | $4.88B | $3.10B | $2.35B | $2.02B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -12.7% | -10.3% | 3.4% | 22.5% | 20.7% | -7.5% | 19.5% | 39.2% | 67.1% | - |
| Net income growth, YoY | 103.9% | -43.3% | -45.0% | -48.2% | - | - | -21.7% | 145.1% | -11.4% | - |
| EPS growth, YoY | 145.0% | -50.8% | -48.7% | -50.2% | - | - | -23.7% | 153.7% | -13.5% | - |
| Gross margin | 62.2% | 53.3% | 45.6% | 41.7% | 41.7% | 44.0% | 38.9% | 33.9% | 35.1% | 48.8% |
| Net margin | 1.7% | 0.7% | 1.2% | 2.2% | 5.2% | -0.2% | 4.1% | 6.3% | 3.6% | 6.8% |
| Free cash flow margin | -5.1% | -4.2% | -1.7% | 1.6% | 1.3% | 6.9% | 4.8% | 5.6% | 5.7% | 6.6% |
| Return on equity | 0.8% | 0.4% | 0.7% | 1.4% | 2.9% | -0.1% | 2.4% | 3.7% | 1.8% | 2.4% |
| Return on assets | 0.3% | 0.1% | 0.2% | 0.5% | 1.0% | -0.0% | 0.9% | 1.4% | 0.8% | 1.0% |
| Current ratio | - | - | - | - | - | - | - | - | 0.94 | 0.64 |
| Debt to equity | 0.08 | 0.09 | 0.07 | 0.08 | 0.08 | 0.07 | 0.06 | 0.07 | 0.07 | 0.75 |
Source: XBRL data Brookfield Corporation files with the SEC, latest filing dated Mar 18, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 3-for-2, first reported Mar 24, 2021; 3-for-2, first reported Mar 18, 2026.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| BN | $75.10B | -12.7% | $1.31B | 1.7% | $101.41B |
| BAM | $5.74B | +31.9% | $3.06B | 53.4% | $84.57B |
| PDM | $581.51M | +2.9% | -$88.29M | -15.2% | $1.23B |
| NEN | $96.39M | +12.1% | -$7.30M | -7.6% | $124.8M |
| MAYS | $21.43M | -3.9% | -$1.15M | -5.4% | $85.0M |
| INTG | $73.95M | +14.9% | $1.64M | 2.2% | $83.1M |
| GYRO | $2.80M | - | -$3.11M | -111.0% | $8.8M |